CTX-M-1- and CTX-M-15-type β-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France

被引:127
作者
Meunier, Daniele
Jouy, Eric
Lazizzera, Corinne
Kobisch, Marylene
Madec, Jean-Yves
机构
[1] Agence Franciase Secur Sanitaire Aliments, Unite Bacteriol Bovine & Secur Viandes, F-69364 Lyon, France
[2] Agence Franciase Secur Sanitaire Aliments, Unite Mycoplasmol Bacteriol, F-22440 Ploufragan, France
关键词
Escherichia coli; food-producing animals; ESBLs; CTX-M-1; CTX-M-15;
D O I
10.1016/j.ijantimicag.2006.08.016
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Clinical Escherichia coli strains with resistance or variable susceptibility to third-generation cephalosporins were detected in cattle, swine and poultry in France. These strains were shown to produce extended-spectrum beta-lactamases (ESBLs), with CTX-M-1- and CTX-M-15-type beta-lactamases being responsible for this phenotype. The bla(CTx-M-1) gene was encountered most commonly and was characterised in seven E. coli strains isolated from cattle, swine and poultry, whereas bla(CTX-M-15) was identified in one E. coli isolated from cattle. These genes were located on a conjugative plasmid and were linked to the insertion sequence ISEcp1, which could have contributed to dissemination of the resistance gene. No epidemiological link between the strains was determined by pulsed-field gel electrophoresis, although two plasmids were identical in two strains isolated from swine and in two strains isolated from cattle and poultry. Thus, this study describes the emergence of ESBLs in animals in France, with a probable similar prevalence rate to that observed in humans. This is a major concern because of the possibility of transfer of these genes between animal species as well as to humans, leading to treatment failures in veterinary and human medicine. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 35 条
[1]
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]
Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States [J].
Alvarez, M ;
Tran, JH ;
Chow, N ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :533-537
[3]
Batchelor Miranda, 2005, Expert Rev Anti Infect Ther, V3, P403, DOI 10.1586/14787210.3.3.403
[4]
Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[5]
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[6]
Characterization of expanded-spectrum cephalosporin resistance in E-coli isolates associated with bovine calf diarrhoeal disease [J].
Bradford, PA ;
Petersen, PJ ;
Fingerman, IM ;
White, DG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (05) :607-610
[7]
Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens [J].
Briñas, L ;
Moreno, MA ;
Zarazaga, M ;
Porrero, C ;
Sáenz, Y ;
García, M ;
Dominguez, L ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2056-2058
[8]
Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003 [J].
Briñas, L ;
Moreno, MA ;
Teshager, T ;
Sáenz, Y ;
Porrero, MC ;
Domínguez, L ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1262-1264
[9]
Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003 [J].
Carattoli, A ;
Lovari, S ;
Franco, A ;
Cordaro, G ;
Di Matteo, P ;
Battisti, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :833-835
[10]
Detection of CTX-M-1 and TEM-52 β-lactamases in Escherichia coli strains from healthy pets in Portugal [J].
Costa, D ;
Poeta, P ;
Briñas, L ;
Sáenz, Y ;
Rodrigues, J ;
Torres, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (05) :960-961